Viewing Study NCT01436968

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2026-02-03 @ 6:00 AM
Study NCT ID: NCT01436968
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-30
First Post: 2011-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Sponsor: Candel Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy View